Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Neuroreport
|
April 20, 1999
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
S M Laws, K Taddei, G Martins, et al.
Neurobiology of Aging
|
May 13, 2008
Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity
K Taddei, S M Laws, G Verdile, et al.
Molecular Psychiatry
|
August 23, 2002
APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss
S M Laws, R M Clarnette, K Taddei, et al.
Journal of Alzheimer'S Disease : JAD
|
June 18, 2004
Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4
M S Burkhardt, J K Foster, S M Laws, et al.
Journal of Alzheimer'S Disease : JAD
|
September 1, 2005
Neurological soft signs are associated with APOE genotype, age and cognitive performance
N T Lautenschlager, Jing-Shan Wu, S M Laws, et al.
Molecular Psychiatry
|
January 7, 2009
Examination of the current top candidate genes for AD in a genome-wide association study
T M Feulner, S M Laws, P Friedrich, et al.
Neurology
|
March 23, 2011
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging
V B Gupta, S M Laws, V L Villemagne, et al.
Molecular Psychiatry
|
October 8, 2014
APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
Y Y Lim, V L Villemagne, S M Laws, et al.
Molecular Psychiatry
|
August 23, 2002
Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population
K Taddei, C Fisher, S M Laws, et al.
Translational Psychiatry
|
July 27, 2012
Olfactory discrimination predicts cognitive decline among community-dwelling older adults
H R Sohrabi, K A Bates, M G Weinborn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Neuroreport
|
April 20, 1999
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
S M Laws, K Taddei, G Martins, et al.
Neurobiology of Aging
|
May 13, 2008
Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity
K Taddei, S M Laws, G Verdile, et al.
Molecular Psychiatry
|
August 23, 2002
APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss
S M Laws, R M Clarnette, K Taddei, et al.
Journal of Alzheimer'S Disease : JAD
|
June 18, 2004
Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4
M S Burkhardt, J K Foster, S M Laws, et al.
Journal of Alzheimer'S Disease : JAD
|
September 1, 2005
Neurological soft signs are associated with APOE genotype, age and cognitive performance
N T Lautenschlager, Jing-Shan Wu, S M Laws, et al.
Molecular Psychiatry
|
January 7, 2009
Examination of the current top candidate genes for AD in a genome-wide association study
T M Feulner, S M Laws, P Friedrich, et al.
Neurology
|
March 23, 2011
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging
V B Gupta, S M Laws, V L Villemagne, et al.
Molecular Psychiatry
|
October 8, 2014
APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
Y Y Lim, V L Villemagne, S M Laws, et al.
Molecular Psychiatry
|
August 23, 2002
Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population
K Taddei, C Fisher, S M Laws, et al.
Translational Psychiatry
|
July 27, 2012
Olfactory discrimination predicts cognitive decline among community-dwelling older adults
H R Sohrabi, K A Bates, M G Weinborn, et al.
Page
of 3